Other studies suggest that CCL2 is a potent pro-inflammatory chemokine that acts as a chemoattractant for myeloid cells and has been extensively studied as a predictor and potential driver of tumor cell growth and metastasis [24,25]. This evidence concerns the gene CCL2 and neoplasm.